DA-EPOCH chemotherapy regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DA-EPOCH chemotherapy regimen, covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia [Phase 2]